C

Codexis
D

CDXS

4.17000
USD
-0.08
(-1.88%)
مغلق
حجم التداول
44,427
الربح لكل سهم
-1
العائد الربحي
-
P/E
-5
حجم السوق
339,345,655
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    CI
    CI
    0.07
    (0.02%)
    299.89 USD
    D
    DRI
    -3.870
    (-1.98%)
    191.210 USD
    ECL
    ECL
    -2.67
    (-1.00%)
    264.80 USD
    FDX
    FDX
    -14.350
    (-5.34%)
    254.190 USD
    KR
    KR
    0.690
    (1.07%)
    65.080 USD
    LEN
    LEN
    -2.100
    (-1.71%)
    120.590 USD
    MCD
    MCD
    1.70
    (0.56%)
    304.74 USD
    ORCL
    ORCL
    -8.190
    (-4.65%)
    167.810 USD
    TJX
    TJX
    -1.850
    (-1.50%)
    121.140 USD
    TRV
    TRV
    -1.190
    (-0.49%)
    240.060 USD
    المزيد
الأخبار
المقالات

العنوان: Codexis

القطاع: Healthcare
الصناعة: Biotechnology
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop and enhance novel, high-performance enzymes. Codexisenzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications.